Hanover, Germany

Matthias Eckhardt


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Matthias Eckhardt: Innovator in Nucleic Acid Research

Introduction: Matthias Eckhardt, based in Hanover, Germany, is a prominent inventor with a focus on nucleic acid research and therapeutic applications. With a remarkable portfolio of four patents, Eckhardt has made significant contributions to the field, particularly in the area of polysialyl transferase activity.

Latest Patents: Eckhardt's latest innovations include isolated nucleic acid molecules that encode mammalian or rodent proteins with polysialyl transferase activity. His patented discoveries detail the intricacies of these proteins, including the specific DNA sequences they are derived from. The applications of his work are notable; the nucleic acid molecules and proteins he developed are poised to be valuable in therapeutic settings, particularly for tumor therapy. Furthermore, he has patented isolated polysialyl transferases, which can be utilized both diagnostically and therapeutically. Additionally, his research includes the development of antisense oligonucleotides and antibodies that may also serve similar purposes.

Career Highlights: Matthias Eckhardt has held key positions at renowned organizations such as Boehringer Mannheim GmbH and the La Jolla Cancer Research Foundation. His work in these companies highlights his commitment to advancing medical research and innovation in the field of molecular biology.

Collaborations: Throughout his career, Eckhardt has collaborated with distinguished colleagues, including Rita Gerardy-Schahn and Minoru Fukuda. These partnerships have allowed for cross-pollination of ideas and have contributed to the advancement of research in polysialyl transferases and their potential applications.

Conclusion: Matthias Eckhardt stands out as a visionary inventor in nucleic acid research. With a solid foundation of patented innovations and valuable collaborations, he is positioned to continue making impactful contributions to therapeutic science, particularly in the realm of cancer treatment. His work not only reflects his expertise but also the promise of his findings in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…